medigraphic.com
SPANISH

Revista Cubana de Investigaciones Biomédicas

ISSN 1561-3011 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (3)

Cardiometabolic vulnerability and biochemical indicators during recruitment of pregnant women and in the postpartum period

Orozco MC, Sarasa MNL, Cañizares LO, Álvarez GGE, Orozco MY, Alonso BN
Full text How to cite this article

Language: Spanish
References: 16
Page: 1-12
PDF size: 218.56 Kb.


Key words:

adiposity, biomarkers, pregnancy, HDL cholesterol, lipoproteins, postpartum, lipid accumulation product, triglycerides.

ABSTRACT

Introduction: Few studies are available about excessive accumulation of adipose tissue and its association to changes in biochemical indicators in pregnancy and the postpartum period.
Objective: Determine the association between cardiometabolic vulnerability due to body adiposity and biochemical indicators during recruitment of pregnant women and in the postpartum period.
Methods: An observational prospective study was conducted of cardiometabolic vulnerability due to body adiposity and biochemical indicators in 773 women recruited as healthy and adequate weight, 119 of them in the postpartum period, at Chiqui Gómez Lubián polyclinic. Biochemical indicators were studied by cardiometabolic vulnerability group at recruitment and in the postpartum period. Statistical analysis was based on the Kruskal-Wallis test.
Results: Pregnant women recruited with overall vulnerability due to high general intermediate and central adiposity had lower uric acid mean values (238.78 mmol/l), higher triglyceride mean values (1.37 mmol/l), cholesterol (4.70 mmol/l) and insulin resistance (8.32). Women with overall vulnerability due to high general intermediate and central adiposity in the postpartum period had higher triglyceride mean values (1.18 mmol/l), very low density lipoproteins (0.54 mmol/l), and lower high density lipoprotein mean values (1.06 mmol/l). Women with extreme overall vulnerability due to high general and central adiposity had higher mean values: glycemia (4.90 mmol/l), cholesterol (4.30 mmol/l), low density lipoproteins (2.76 mmol/l), lipid accumulation product (42.63 mmol/l) and visceral adiposity index (2.32 mmol/l).
Conclusions: Evaluating cardiometabolic vulnerability using anthropometric techniques complemented with biochemical indicators, facilitates aiming preventive actions at progressive cardiometabolic damage during pregnancy and the postpartum period.


REFERENCES

  1. Hernández Rodríguez J. La obesidad y la inflamación crónica de bajo grado. Rev Cubana Endocr. 2018 [acceso: 21/06/2020];29(3). Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-29532018000300001&script=sci_arttext&tlng=en

  2. Reyes JM. Características biológicas del tejido adiposo: el adipocito como célula endocrina. Rev Méd Clín Las Condes. 2012 [acceso: 19/062020];23(2). Disponible en: https://www.sciencedirect.com/science/article/pii/S0716864012702900

  3. Orozco Muñoz C, Cañizares Luna O, Sarasa Muñoz N. Postpartum Obesity in Cuba: Risk Outweighs Response. Int J Cuban Health Med. 2017 [acceso03/04/2020];19(2-3):[75]. Disponible en: https://www.scielosp.org/pdf/medicc/2017.v19n2-3/75-75/en

  4. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy Experience. Geneva: WHO; 2016. [acceso: 23/04/2020]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/250796/9789241549912-eng.pdf?sequence=1

  5. Patti AM, Pafili K, Papanas N, Rizzo M. Metabolic disorders during pregnancy and postpartum cardiometabolic risk. Endocr Connection. 2018 [acceso: 11/03/2020];7(5). Disponible en: https://ec.bioscientifica.com/view/journals/ec/7/5/EC-18-0130.xml

  6. Bertram V. Maternal characteristics associated with cardiometabolic status in early pregnancy. [Tesis]. Canadá: McMaster University; 2017. [acceso: 11/03/2020]. Disponible en: https://macsphere.mcmaster.ca/handle/11375/22197

  7. Ferriols E, Rueda C, Gamero R, Vidal M, Payá A, Carreras R, et al. Comportamiento de los lípidos durante la gestación y su relación con acontecimientos obstétricos desfavorables. Clin Biochem Investig Arterioscler. 2016 [acceso: 20/05/2020];28(5). Disponible en: http://www.enfermeriaaps.com/portal/wp-content/uploads/2016/11/Comportamient-de-los-l%C3%ADpidos-durante-la-gestaci%C3%B3n.pdf

  8. Widen E, Gallagher D. Body composition changes in pregnancy: measurement, predictors and outcomes. Eur J Clin Nutr. 2014 [acceso: 06/03/2020];68:643-52. Disponible en: https://www.nature.com/articles/ejcn201440

  9. Cuba. Ministerio de Salud Pública. Programa Nacional de Atención Materno Infantil 1999. La Habana: MINSAP; 1999. [acceso: 10/04/2020]. Disponible en: http://files.sld.cu/sida/files/2012/01/programa-nacional-de-atencion-materno-infantil-1999.pdf

  10. Orozco Muñoz C, Sarasa Muñoz NL, Hernández Díaz D, Cañizares Luna O, Álvarez Guerra E, Artiles Santana A. Indicadores antropométricos para la caracterización de la adiposidad corporal en gestantes sanas al inicio del embarazo. CorSalud. 2018 [acceso: 31/05/2020];10(4). Disponible en: http://scielo.sld.cu/pdf/cs/v10n4/2078-7170-cs-10-04-274.pdf

  11. Orozco Muñoz C, Cañizares Luna O, Sarasa Muñoz N. Estado nutricional, acumulación de tejido adiposo y vulnerabilidad cardiometabólica en gestantes sanas de peso adecuado. Gac Méd Espirit. 2018 [acceso: 20/05/2020];20(2). Disponible en: http://scielo.sld.cu/pdf/gme/v20n2/1608-8921-gme-20-02-40.pdf

  12. Orozco Muñoz C, Cañizares Luna O, Sarasa Muñoz N, Artiles Santana A, Morales Molina X, Cairo Saez G. ¿Qué evaluar en la gestante sana de peso adecuado al inicio de la gestación: índice de masa corporal o adiposidad corporal? CorSalud. 2018 [acceso: 06/05/2020];10(1). Disponible en: http://scielo.sld.cu/pdf/cs/v10n1/cs14118.pdf

  13. García Alonzo L, Carías Picón D, Acosta García E. Factores de riesgo cardiovascular lipídicos y no lipídicos en una población adulta. Acta Bioquim Clin Latinoam. 2016 [acceso: 20/05/2020];50(4). Disponible en: https://www.redalyc.org/pdf/535/53550527008.pdf

  14. Cardellá Rosales L, Valdés Moreno J, Gómez Álvarez A, Hernández Fernández M. Estado nutricional de la gestante y su repercusión sobre el lipidograma durante el embarazo. Panorama Cuba Salud. 2013 [acceso: 08/05/2020];8(2). Disponible en: https://www.medigraphic.com/pdfs/cubaysalud/pcs-2013/pcs132d.pdf

  15. De Souza LR, Kogan E, Berger H, Alves JG, Lebovic G, Retnakaran R, et al. Abdominal adiposity and insulin resistance in early pregnancy. J Obstet Gynaecol. 2014 [acceso: 08/06/2020];36(11). Disponible en: https://www.sciencedirect.com/science/article/pii/S1701216315304096

  16. Loy SL, Cheung YB, Soh SE, Ng S, Tint MT, Aris IM, et al. Female adiposity and time-to-pregnancy: a multiethnic prospective cohort. Hum Reprod. 2018;33(11). PMCID: PMC6201836




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Invest Bioméd. 2021;40